|
Towards patient-centric drug discovery: Drug action in malignant pleural effusions and ascites using high content imaging and deep learning. |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research Funding - Allcyte (Inst) |
|
|
Research Funding - Allcyte (Inst) |
|
|
Research Funding - Allcyte (Inst) |
|
|
Research Funding - Allcyte (Inst) |
|
|
Research Funding - Allcyte (Inst) |
|
|
Research Funding - Allcyte (Inst) |
|
|
Honoraria - Accord Healthcare; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Roche; Sanofi |
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Boehringer Ingelheim; Merck; MSD; Roche |
Research Funding - Allcyte (Inst); Bristol-Myers Squibb; Merck; MSD |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; MSD; Roche |
|
|
|
|
Stock and Other Ownership Interests - Allcyte |
Patents, Royalties, Other Intellectual Property - Inventor on multiple patents regarding screening technology and analysis algorithms that are owned by a previous employer and licensed by the company I work for. |